This study is in progress, not accepting new patients
Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease
Summary
- Eligibility
- for people ages 50-78 (full criteria)
- Location
- at Orange, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- BlueRock Therapeutics
- ID
- NCT04802733
- Phase
- Phase 1 Parkinson's Disease Research Study
- Study Type
- Interventional
- Participants
- About 12 people participating
- Last Updated